Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

An Inspiring Company Needs Aspiring Employees

Here are some steps to help your employees aspire towards success once more and help lift the image of your inspiring company at the same time. . . . → Read More: An Inspiring Company Needs Aspiring Employees

California Set to Pioneer Blockchain ATMs in MMJ Dispensaries Statewide

California will see a new form of blockchain cryptocurrency POS terminals in key medical marijuana dispensaries around the state. . . . → Read More: California Set to Pioneer Blockchain ATMs in MMJ Dispensaries Statewide

U.S. Public Divided Over GM, Organic Food

The American public is almost evenly divided about the benefits of genetically-modified and organic food, with those divisions not breaking along easily defined or familiar lines. . . . → Read More: U.S. Public Divided Over GM, Organic Food

Targeted Leukemia Drugs Sharply Raising Costs of Care

Drugs directly attacking cancer cell growth show high remission rates with a common form of leukemia, but a new study suggests the high costs of these drugs could impose difficult economic burdens on patients and the health care system. . . . → Read More: Targeted Leukemia Drugs Sharply Raising Costs of Care

Health Insurance Group Forms Academic Research Network

The national organization of Blue Cross-Blue Shield health insurance providers is linking up with academic researchers to study outcomes of health care practices, including opioid abuse and cancer screenings. . . . → Read More: Health Insurance Group Forms Academic Research Network

Breast Cancer Drug Costs Vary Among Insured Patients

Women receiving chemotherapy for breast cancer can face widely different costs for their treatments, regardless of effectiveness, even if they have health insurance. . . . → Read More: Breast Cancer Drug Costs Vary Among Insured Patients

Malnutrition Shown Adding Billions to U.S. Health Costs

An analysis of data from health surveys shows malnutrition associated with 8 common chronic diseases adds $15.5 billion directly to U.S. health care costs. . . . → Read More: Malnutrition Shown Adding Billions to U.S. Health Costs

Drug Reconciliation Program Cuts Hospital Readmission

Consultations with pharmacists on medications when patients leave the hospital for home are shown to reduce the rate of readmission to the hospital by half. . . . → Read More: Drug Reconciliation Program Cuts Hospital Readmission

More Device Approvals, Higher Risks in Europe than U.S.

(PublicDomainPictures, Pixabay)

29 June 2016. An analysis of regulatory approvals and outcomes shows medical devices are reviewed and approved faster in Europe than the U.S., but also face more safety issues later on. A team from Kings College London and Harvard University published its findings yesterday in the journal BMJ.

Researchers led by Aaron . . . → Read More: More Device Approvals, Higher Risks in Europe than U.S.

New Diabetic Eye Disease Drugs Shown Not Cost-Effective

(TBIT/Pixabay)

10 June 2016. An evaluation of two new biologic drugs to treat diabetic macular edema, an eye disease caused by diabetes, show the drugs do not provide enough additional benefit over much less expensive treatments to justify their higher price tags. The team led by Adam Glassman of the Jaeb Center for Health . . . → Read More: New Diabetic Eye Disease Drugs Shown Not Cost-Effective